Mammograms have become extremely useful in identifying suspect lesions that may be cancer, but biopsies are still required to actually find out whether the tissue is cancerous.
Researchers at University of Michigan have developed a molecule, which can be delivered in pill form, that connects to cell surface receptors on certain types of cancer cells. The molecule has a fluorescent component on it, so when it’s illuminated with infrared light, it itself glows in response. This may allow the technique to be particularly useful in breast cancer, and potentially overcoming mammograms altogether by providing both imaging and diagnosis in one step.
One major achievement of the project was developing a particle that would end up in the blood system following delivery via a pill and that it would fluoresce well enough to be seen.
Here’s a University of Michigan video about the project:
Via: University of Michigan…
You may be interested
Three takeaways on the VA, VistA and government health ITFrank - Apr 24, 2019
A new study from the U.S. Government Accountability Office dug deeper into what’s happening with the Department of Veterans Affairs and…
People are talking about this Bojack Horseman episode in light of the Las Vegas mass shootingFrank - Apr 24, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/tv/news/bojack-horseman-season-4-thoughts-and-prayers-a7982226.html
Netflix sets release date for ‘terrifying’ supernatural series DarkFrank - Apr 24, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/tv/news/dark-netflix-release-date-german-language-teaser-trailer-a7982216.html